Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers
BUSINESS DIRECTORY PRODUCT CATALOG PHARMACEUTICAL CATALOGS PHARMA TRADE LEADS EXPORT IMPORT POLICIES POLICIES & ORDERS

Home » Pharmaceutical Drugs » Pharmaceutical Finished Formulations » Tablets »

Finished Formulations
Pharmaceutical Drugs

Glossary



GLICLAZIDE


Gliclazide is an anti-diabetic agent with both metabolic and vascular properties. It restores the early peak of insulin secretion and ensures glycaemic control throughout 24 hours without hypoglycaemia.

The drug combats microthrombosis by decreasing platelet hyper adhesiveness & hyper aggregation, increasing fibrinolytic activity, normalizing prostaglandin metabolism, scavenging free-radicals.

The drug is also used in combination with a strict diet and exercising regime for controlling high blood sugar in non-insulin dependent diabetic patients.

Brand Name: Amaryl, DiaBeta, Diabinese, Dymelor, Glucotrol, Glucotrol XL

Chemical Description

Dosage
80-320 mg daily. Usually160 mg daily.

Contra- Indications: Pregnancy, Severe renal or hepatic failure, severe ketosis, acidosis, diabetic precoma and coma.

Side Effects
The drug has certain side effects, that can affect individuals in different ways. The following are some of the side effects, that are often associated with the drug:
  • Cutaneous reactions
  • Blood dyscrasias

Disclaimer: The above information is for general understanding of the visitor. Please consult a registered medical practitioner before taking the aforesaid medicine.